Brief: Spectrum Pharmaceuticals Notified By Nasdaq That Co No Longer Complies With Minimum Bid Price Requirement
08/11/2022 12:09
Nov 8 (Reuters) - Spectrum Pharmaceuticals Inc SPPI.O :
* SPECTRUM PHARMACEUTICALS INC - ON NOVEMBER 2, RECEIVED
NOTICE
FROM NASDAQ THAT CO NO LONGER COMPLIES WITH MINIMUM BID PRICE
REQUIREMENT
Source text for Eikon: ID:
Further company coverage: SPPI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Spectrum Pharmaceuticals
See all newsBrief: Assertio Holdings Announces Favorable Vote On Proposed Acquisition Of Spectrum Pharmaceuticals
Brief: Independent Proxy Advisory Firms ISS And Glass Lewis Recommend Spectrum Pharmaceuticals Stockholders Vote “For” Proposed Deal With Assertio Holdings, Inc.
Brief: Spectrum Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirement
U.S. RESEARCH ROUNDUP-CTI Biopharma, Park National, Playags
Spectrum Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary